ADMA Biologics Inc Stock News

RAMSEY, N.J. and BOCA RATON, Fla., Sept. 23, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufactu

The FDA has approved ADMA Biologics Inc's (NASDAQ:ADMA) in-house aseptic fill-finish machine, the VanRx SA25. Related Content:   ADMA Biologics Stock Gains On FDA Approval For Plasma Collection Fa

RAMSEY, N.J. and BOCA RATON, Fla., Sept. 02, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufactu

Last week, there were three significant developments with respect to ADMA. The market has taken these events to be bearish for ADMA's outlook, with the stock selling off this week.

The shares of ADMA Biologics Inc (NASDAQ: ADMA) increased by over 15% pre-market. This is why it happened.

RAMSEY, N.J. and BOCA RATON, Fla. and MARYVILLE, Tenn., Aug. 16, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated

ADMA Biologics: Feeling Bullish After Encouraging Q2 Earnings Report

ADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q2 2021 Results - Earnings Call Transcript

Adma Biologics (ADMA) delivered earnings and revenue surprises of 0.00% and 7.73%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Achieved Record Total Revenues of $17.8 Million in Second Quarter 2021, a 129% Increase Over Second Quarter 2020

RAMSEY, N.J. and BOCA RATON, Fla. and CONYERS, Ga., Aug. 10, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to

ADMA Expands Commercial IG Product Offering with Additional BIVIGAM and NABI-HB Vial Sizes

Conference Call Scheduled for August 11, 2021 at 4:30 p.m. ET Conference Call Scheduled for August 11, 2021 at 4:30 p.m. ET

Some of the stocks that may grab investor focus today are: Wall Street expects Hewlett Packard Enterprise Co (NYSE: HPE) to post quarterly earnings at $0.42 per share on revenue of $6.62 billion after

ADMA delivered another great quarter and is poised to experience revenue growth and margin expansion and has a path to profitability.